Brief: Urogen Secures $100 Mln Non-Dilutive Term Loan Financing With Pharmakon Advisors
08/03/2022 13:18
March 8 (Reuters) - Urogen Pharma Ltd UR8.F :
* UROGEN SECURES $100 MILLION NON-DILUTIVE TERM LOAN FINANCING WITH
PHARMAKON
ADVISORS ALLOWING FUNDING TO CASH FLOW BREAKEVEN
Source text for Eikon: ID:nBw8XxkBra
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors